Director, Strategic Alliances & External Engagement – Medical Affairs

“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone.  Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor.  Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky”

Mineralys is a fully remote company.

Role Overview

The Director of Strategic Alliances & External Engagement is a senior leader within Medical Affairs responsible for developing and executing a cross-functional coordinated engagement strategy that strengthens Mineralys’ scientific leadership in cardio-renal-metabolic disorders. This role drives collaboration across academic institutions, professional societies, patient advocacy organizations, and other key external stakeholders to support the full product lifecycle of lorundrostat, Mineralys’ first-in-class aldosterone synthase inhibitor.

By aligning external partnerships with the company’s medical and corporate objectives, this leader ensures that actionable insights, scientific data, and real-world evidence shape how Mineralys advances its mission to improve outcomes for patients with uncontrolled and resistant hypertension.

Core responsibilities

• Forge and manage strategic partnerships.
• Identify, evaluate, and cultivate high-impact relationships with leading academic investigators, clinical networks, professional societies, and patient advocacy groups within the hypertension and broader CRM community.
• Build collaborative frameworks that expand scientific exchange, facilitate data generation, and amplify Mineralys’ visibility in the field.